Summary

Orthopedic Regenerative Surgical Products Market Growth & Trends

The global orthopedic regenerative surgical products market size is anticipated to reach USD 5.2 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a notable CAGR of 3.6% from 2021 to 2028. The key factors driving the market growth include the rising geriatric population, orthopedic procedures, research activities, and technological advancements. Osteoarthritis, for instance, has been identified as the leading cause of chronic disability in the geriatric population over the age of 70. The World Health Organization (WHO) has also designated osteoarthritis as a ‘priority disease’ promoting R&D for therapies to treat osteoarthritis and its associated symptoms.

The growth of the market was restrained during the COVID-19 pandemic due to deferred elective surgeries, low volume of patient flow for chronic conditions in clinics and hospitals, decreased sales and marketing activities, quarantine and lockdown protocols, and low demand. Vericel Corporation, for example, reported the adverse impact of COVID-19 on its business and operations during 2020. The company registered cancellations of scheduled MACI procedures; its key product used in the repair of cartilage damage of the knee. In addition, there was a slowdown in new orders. Anika Therapeutics reported challenges in patient enrollment for its clinical trials due to the pandemic, which negatively impacted on the company’s revenue and operating results. However, both companies expect recovery financial performance as elective surgeries resume to pre-COVID numbers.

According to the Centers for Disease Control and Prevention (CDC), about 26% (or 78 million) the U.S. adults are estimated to suffer from arthritis by 2040. The prevalence increases with age and is found to be more common in women. Obesity has been identified as another risk factor contributing to orthopedic conditions. The prevalence of obesity in the U.S. was estimated at 42.4% from 2017 to 2018 by the CDC. The increasing prevalence of orthopedic diseases, obesity, and geriatric population is expected to fuel the market growth. Orthopedic regenerative surgical products find application in different conditions of varying severity from joint pain, gout, articular defects, fibromyalgia, and osteoarthritis, to trauma and joint replacement, this is expected to contribute to the market growth.

Market players are also involved in research and development activities to launch new regenerative solutions for treatment or pain relief from orthopedic conditions. Amniox Medical, Inc. for instance, received FDA clearance to proceed with a dosing study using TTAX03- its Investigational New Drug (IND) comprising cryopreserved amniotic membrane and umbilical cord, to treat facet joint osteoarthritis pain in March 2021. Zimmer Biomet on the other hand, offers an extensive portfolio of allografts and synthetic orthopedic regenerative products such as the PrimaGen Advanced allograft, InterGro DBM, and PlatFORM bioresorbable bone graft substitute.

Orthopedic Regenerative Surgical Products Market Report Highlights

• Key factors driving the market include an aging population across the globe and a rise in the prevalence of orthopedic diseases. According to a 2019 review article published in the Elderly Health Journal, the prevalence of knee osteoarthritis in various Asian countries was found to be in a range of 13.1 - 71.1%

• The viscosupplements segment dominated the market and accounted for the largest revenue share of 42.7% in 2020 owing to the increasing prevalence of osteoarthritis and related symptoms and product availability

• Monovisc and Orthovisc by Anika Therapeutics are the leading products in the viscosupplement market in the U.S. since 2018, based on combined overall revenue

• In terms of application, the cartilage and tendon repair segment is estimated to witness the fastest CAGR of 3.8% followed by trauma repair and orthopedic pain management

• According to a 2019 study on Cartilage Restoration Surgery published by the National Library of Medicine, complications in cartilage restoration procedures have been rising for the past 2 decades. The results also indicated a paradigm shift toward osteochondral grafting procedures and other more complex cartilage procedures

• As most orthopedic procedures are performed within hospital settings, the hospitals segment held the largest revenue share of 50.4% in 2020

• Drivers include a large number of populations affected by joint pain and other debilitating orthopedic conditions and supportive initiatives by governments and regulatory bodies. For example, 12 October was established as the World Arthritis Day by the Arthritis and Rheumatism International (ARI)to raise awareness about rheumatic and musculoskeletal diseases

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment scope
1.1.2 Regional scope
1.1.3 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased database
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.7 List of Secondary Sources
1.8 Objectives
Chapter 2 Executive Summary
2.1 Orthopedic Regenerative Surgical Products Market Summary
Chapter 3 Orthopedic Regenerative Surgical Products Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Penetration & Growth Prospect Mapping, 2020
3.3 Orthopedic Regenerative Surgical Products Market Dynamics
3.3.1 Market driver analysis
3.3.1.1. Increasing prevalence of orthopedic conditions
3.3.1.2. Aging population
3.3.1.3. Rising R&D activities and technological advancements
3.3.1.4. Increasing preference for minimally invasive surgeries
3.3.1.5. Emergence of new materials and indications for Orthopedic Regenerative Surgical Products
3.3.2 Market restraint analysis
3.3.2.1. High cost of treatment
3.3.2.2. Stringent regulatory norms
3.3.2.3. Risk of disease transmission
3.3.3. Market opportunity analysis
3.3.4. Market challenge analysis
3.4 Orthopedic Regenerative Surgical Products Market Analysis Tools: Porters
3.4.1 Supplier Power
3.4.2. Buyer Power
3.4.3. Threat of substitutes
3.4.4. Threat of New Entrants
3.4.5. Competitive Rivalry
3.5 Orthopedic Regenerative Surgical Products Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
3.5.1 Political/Legal Landscape
3.5.2 Economic Landscape
3.5.3 Social Landscape
3.5.4 Technology Landscape
3.6. Regulatory and Reimbursement Landscape
3.7. Technology Trend Analysis
3.8. Product Pipeline Analysis
3.9. Orthopedic Disease Prevalence
3.10. User Perspective Analysis
Chapter 4 COVID-19 Impact Analysis
4.1 COVID-19 Prevalence Analysis
4.2. Regulatory requirements/changes due to COVID-19
4.3. Strategies implemented by companies
Chapter 5 Orthopedic Regenerative Surgical Products Market: Segment Analysis, By Product, 2016 - 2028 (USD Million)
5.1 Product Market Share Analysis, 2020 & 2028
5.2 Orthopedic Regenerative Surgical Products market, by Product, 2016 to 2028
5.3 Allografts
5.3.1 Allografts market, 2016 - 2028 (USD Million)
5.3.1.1 Amniotic Products
5.3.1.1.1 Amniotic Products market, 2016 - 2028 (USD Million)
5.3.1.2. Others
5.3.1.2.1 Others market, 2016 - 2028 (USD Million)
5.4 Synthetic
5.4.1 Synthetic market, 2016 - 2028 (USD Million)
5.5 Cell-based
5.5.1 Cell-based market, 2016 - 2028 (USD Million)
5.6 Viscosupplements
5.6.1 Viscosupplements market, 2016 - 2028 (USD Million)
Chapter 6 Orthopedic Regenerative Surgical Products Market: Segment Analysis, By Application, 2016 - 2028 (USD Million)
6.1 Application Market Share Analysis, 2020 & 2028
6.2 Orthopedic Regenerative Surgical Products market, by Application, 2016 to 2028
6.3 Orthopedic Pain Management
6.3.1 Orthopedic Pain Management market, 2016 - 2028 (USD Million)
6.4 Trauma Repair
6.4.1 Trauma Repair market, 2016 - 2028 (USD Million)
6.5 Cartilage & tendon repair
6.5.1 Cartilage & tendon repair market, 2016 - 2028 (USD Million)
6.6 Joint reconstruction
6.6.1 Joint reconstruction market, 2016 - 2028 (USD Million)
6.7 Others
6.7.1 Others market, 2016 - 2028 (USD Million)
Chapter 7 Orthopedic Regenerative Surgical Products Market: Segment Analysis, By End User, 2016 - 2028 (USD Million)
7.1 End-user Market Share Analysis, 2020 & 2028
7.2 Orthopedic Regenerative Surgical Products Market, By End User, 2016 to 2028
7.3 Hospitals
7.3.1 Hospitals market, 2016 - 2028 (USD Million)
7.4 Ambulatory Surgical Centers
7.4.1 Ambulatory Surgical Centers market, 2016 - 2028 (USD million)
7.5 Others
7.5.1 Others market, 2016 - 2028 (USD Million)
Chapter 8 Orthopedic Regenerative Surgical Products Market: Regional Market Analysis 2016 - 2028 (USD Million)
8.1 Definition & Scope
8.2 Regional Movement Analysis, 2020 & 2028
8.3 Regional Market Snapshot
8.4 North America
8.4.1 North America Orthopedic Regenerative Surgical Products Market, 2016 - 2028 (USD Million)
8.4.2. U.S.
8.4.2.1 U.S. Orthopedic Regenerative Surgical Products Market, 2016 - 2028 (USD Million)
8.4.3 Canada
8.4.3.1 Canada Orthopedic Regenerative Surgical Products Market, 2016 - 2028 (USD Million)
8.5 Europe
8.5.1 Europe Orthopedic Regenerative Surgical Products Market, 2016 - 2028 (USD Million)
8.5.2 U.K.
8.5.2.1 U.K. Orthopedic Regenerative Surgical Products Market, 2016 - 2028 (USD Million)
8.5.3 Germany
8.5.3.1 Germany Orthopedic Regenerative Surgical Products Market, 2016 - 2028 (USD Million)
8.5.4 France
8.5.4.1 France Orthopedic Regenerative Surgical Products Market, 2016 - 2028 (USD Million)
8.5.5 Italy
8.5.5.1 Italy Orthopedic Regenerative Surgical Products Market, 2016 - 2028 (USD Million)
8.5.6 Spain
8.5.6.1 Spain Orthopedic Regenerative Surgical Products Market, 2016 - 2028 (USD Million)
8.6 Asia Pacific
8.6.1 Asia Pacific Orthopedic Regenerative Surgical Products market, 2016 - 2028 (USD Million)
8.6.2 Japan
8.6.2.1 Japan Orthopedic Regenerative Surgical Products Market, 2016 - 2028 (USD Million)
8.6.3 China
8.6.3.1 China Orthopedic Regenerative Surgical Products Market, 2016 - 2028 (USD million)
8.6.4 India
8.6.4.1 India Orthopedic Regenerative Surgical Products Market, 2016 - 2028 (USD Million)
8.7 Latin America
8.7.1 Latin America Orthopedic Regenerative Surgical Products Market, 2016 - 2028 (USD Million)
8.7.2 Brazil
8.7.2.1 Brazil Orthopedic Regenerative Surgical Products Market, 2016 - 2028 (USD Million)
8.7.3 Mexico
8.7.3.1 Mexico Orthopedic Regenerative Surgical Products Market, 2016 - 2028 (USD Million)
8.7.4 Argentina
8.7.4.1 Argentina Orthopedic Regenerative Surgical Products Market, 2016 - 2028 (USD Million)
8.8 MEA
8.8.1 MEA Orthopedic Regenerative Surgical Products Market, 2016 - 2028 (USD Million)
8.8.2 South Africa
8.8.2.1 South Africa Orthopedic Regenerative Surgical Products Market, 2016 - 2028 (USD Million)
8.8.3 Saudi Arabia
8.8.3.1 Saudi Arabia Orthopedic Regenerative Surgical Products Market, 2016 - 2028 (USD Million)
Chapter 9 Orthopedic Regenerative Surgical Products Market - Competitive Analysis
9.1 Market Participant Categorization
9.1.1. Company Market Position Analysis
9.1.2. Synergy Analysis: Major Deals & Strategic Alliances
9.1.3. Market Leaders
9.1.4. Innovators
9.2. List of Key Companies
Chapter 10 Orthopedic Regenerative Surgical Products Market - Company Profiles
10.1 Baxter
10.1.1 Company overview
10.1.2 FINANCIAL PERFORMANCE
10.1.3 Product benchmarking
10.1.4 Strategic initiatives
10.2 Zimmer Biomet
10.2.1 Company overview
10.2.2 Financial performance
10.2.3 Product benchmarking
10.2.4 Strategic initiatives
10.3 Stryker
10.3.1 Company overview
10.3.2 Financial performance
10.3.3 Product benchmarking
10.3.4 Strategic initiatives
10.4 Smith+Nephew
10.4.1 Company overview
10.4.2 Financial performance
10.4.3 Product benchmarking
10.4.4 Strategic initiatives
10.5 AlloSource
10.5.1 Company overview
10.5.2 Financial performance
10.5.3 Product benchmarking
10.5.4 Strategic initiatives
10.6 Amniox Medical, Inc.
10.6.1 Company overview
10.6.2 Financial performance
10.6.3 Product benchmarking
10.6.4 Strategic initiatives
10.7 Anika Therapeutics, Inc.
10.7.1 Company overview
10.7.2 Financial performance
10.7.3 Product benchmarking
10.7.4 Strategic initiatives
10.8 Vericel Corporation
10.8.1 Company overview
10.8.2 Financial performance
10.8.3 Product benchmarking
10.8.4 Strategic initiatives
10.9 VSY Biotechnology
10.9.1 Company overview
10.9.2 Financial performance
10.9.3 Product benchmarking
10.9.4 Strategic initiatives
10.10 Aptissen S.A
10.10.1 Company overview
10.10.2 Financial performance
10.10.3 Product benchmarking
10.10.4 Strategic initiatives
10.11 MiMedx
10.11.1 Company overview
10.11.2 Financial performance
10.11.3 Product benchmarking
10.11.4 Strategic initiatives




List of Tables

Table 1 List of secondary sources
Table 2 List of Key companies
Table 3 North America Orthopedic Regenerative Surgical Products market, by country, 2016 - 2028 (USD Million)
Table 4 North America Orthopedic Regenerative Surgical Products market, by product, 2016 - 2028 (USD Million)
Table 5 North America Orthopedic Regenerative Surgical Products market, by end user, 2016 - 2028 (USD Million)
Table 6 North America Orthopedic Regenerative Surgical Products market, by application, 2016 - 2028 (USD Million)
Table 7 North America Products market, by allografts, 2016 - 2028 (USD Million)
Table 8 U.S. Orthopedic Regenerative Surgical Products market, by product, 2016 - 2028 (USD Million)
Table 9 U.S. Orthopedic Regenerative Surgical Products market, by end user, 2016 - 2028 (USD Million)
Table 10 U.S. Orthopedic Regenerative Surgical Products market, by application, 2016 - 2028 (USD Million)
Table 11 U.S. Products market, by allografts, 2016 - 2028 (USD Million)
Table 12 Canada Orthopedic Regenerative Surgical Products market, by product, 2016 - 2028 (USD Million)
Table 13 Canada Orthopedic Regenerative Surgical Products market, by end user, 2016 - 2028 (USD Million)
Table 14 Canada Orthopedic Regenerative Surgical Products market, by application, 2016 - 2028 (USD Million)
Table 15 Canada Products market, by allografts, 2016 - 2028 (USD Million)
Table 16 Europe Orthopedic Regenerative Surgical Products market, by country, 2016 - 2028 (USD Million)
Table 17 Europe Orthopedic Regenerative Surgical Products market, by product, 2016 - 2028 (USD Million)
Table 18 Europe Orthopedic Regenerative Surgical Products market, by end user, 2016 - 2028 (USD Million)
Table 19 Europe Orthopedic Regenerative Surgical Products market, by application, 2016 - 2028 (USD Million)
Table 20 Europe Products market, by allografts, 2016 - 2028 (USD Million)
Table 21 U.K. Orthopedic Regenerative Surgical Products market, by product, 2016 - 2028 (USD Million)
Table 22 U.K. Orthopedic Regenerative Surgical Products market, by end user, 2016 - 2028 (USD Million)
Table 23 U.K. Orthopedic Regenerative Surgical Products market, by application, 2016 - 2028 (USD Million)
Table 24 U.K. Products market, by allografts, 2016 - 2028 (USD Million)
Table 25 Germany Orthopedic Regenerative Surgical Products market, by product, 2016 - 2028 (USD Million)
Table 26 Germany Orthopedic Regenerative Surgical Products market, by end user, 2016 - 2028 (USD Million)
Table 27 Germany Orthopedic Regenerative Surgical Products market, by application, 2016 - 2028 (USD Million)
Table 28 Germany Products market, by allografts, 2016 - 2028 (USD Million)
Table 29 France Orthopedic Regenerative Surgical Products market, by product, 2016 - 2028 (USD Million)
Table 30 France Orthopedic Regenerative Surgical Products market, by end user, 2016 - 2028 (USD Million)
Table 31 France Orthopedic Regenerative Surgical Products market, by application, 2016 - 2028 (USD Million)
Table 32 France Products market, by allografts, 2016 - 2028 (USD Million)
Table 33 Italy Orthopedic Regenerative Surgical Products market, by product, 2016 - 2028 (USD Million)
Table 34 Italy Orthopedic Regenerative Surgical Products market, by end user, 2016 - 2028 (USD Million)
Table 35 Italy Orthopedic Regenerative Surgical Products market, by application, 2016 - 2028 (USD Million)
Table 36 Italy Products market, by allografts, 2016 - 2028 (USD Million)
Table 37 Spain Orthopedic Regenerative Surgical Products market, by product, 2016 - 2028 (USD Million)
Table 38 Spain Orthopedic Regenerative Surgical Products market, by end user, 2016 - 2028 (USD Million)
Table 39 Spain Orthopedic Regenerative Surgical Products market, by application, 2016 - 2028 (USD Million)
Table 40 Spain Products market, by allografts, 2016 - 2028 (USD Million)
Table 41 Asia Pacific Orthopedic Regenerative Surgical Products market, by country, 2016 - 2028 (USD Million)
Table 42 Asia Pacific Orthopedic Regenerative Surgical Products market, by product, 2016 - 2028 (USD Million)
Table 43 Asia Pacific Orthopedic Regenerative Surgical Products market, by end user, 2016 - 2028 (USD Million)
Table 44 Asia Pacific Orthopedic Regenerative Surgical Products market, by application, 2016 - 2028 (USD Million)
Table 45 Asia Pacific Products market, by allografts, 2016 - 2028 (USD Million)
Table 46 China Orthopedic Regenerative Surgical Products market, by product, 2016 - 2028 (USD Million)
Table 47 China Orthopedic Regenerative Surgical Products market, by end user, 2016 - 2028 (USD Million)
Table 48 China Orthopedic Regenerative Surgical Products market, by application, 2016 - 2028 (USD Million)
Table 49 China Products market, by allografts, 2016 - 2028 (USD Million)
Table 50 Japan Orthopedic Regenerative Surgical Products market, by product, 2016 - 2028 (USD Million)
Table 51 Japan Orthopedic Regenerative Surgical Products market, by end user, 2016 - 2028 (USD Million)
Table 52 Japan Orthopedic Regenerative Surgical Products market, by application, 2016 - 2028 (USD Million)
Table 53 Japan Products market, by allografts, 2016 - 2028 (USD Million)
Table 54 India Orthopedic Regenerative Surgical Products market, by product, 2016 - 2028 (USD Million)
Table 55 India Orthopedic Regenerative Surgical Products market, by end user, 2016 - 2028 (USD Million)
Table 56 India Orthopedic Regenerative Surgical Products market, by application, 2016 - 2028 (USD Million)
Table 57 India Products market, by allografts, 2016 - 2028 (USD Million)
Table 58 Latin America Orthopedic Regenerative Surgical Products market, by country, 2016 - 2028 (USD Million)
Table 59 Latin America Orthopedic Regenerative Surgical Products market, by product, 2016 - 2028 (USD Million)
Table 60 Latin America Orthopedic Regenerative Surgical Products market, by end user, 2016 - 2028 (USD Million)
Table 61 Latin America Orthopedic Regenerative Surgical Products market, by application, 2016 - 2028 (USD Million)
Table 62 Latin America Products market, by allografts, 2016 - 2028 (USD Million)
Table 63 Brazil Orthopedic Regenerative Surgical Products market, by product, 2016 - 2028 (USD Million)
Table 64 Brazil Orthopedic Regenerative Surgical Products market, by end user, 2016 - 2028 (USD Million)
Table 65 Brazil Orthopedic Regenerative Surgical Products market, by application, 2016 - 2028 (USD Million)
Table 66 Brazil Products market, by allografts, 2016 - 2028 (USD Million)
Table 67 Mexico Orthopedic Regenerative Surgical Products market, by product, 2016 - 2028 (USD Million)
Table 68 Mexico Orthopedic Regenerative Surgical Products market, by end user, 2016 - 2028 (USD Million)
Table 69 Mexico Orthopedic Regenerative Surgical Products market, by application, 2016 - 2028 (USD Million)
Table 70 Mexico Products market, by allografts, 2016 - 2028 (USD Million)
Table 71 Argentina Orthopedic Regenerative Surgical Products market, by product, 2016 - 2028 (USD Million)
Table 72 Argentina Orthopedic Regenerative Surgical Products market, by end user, 2016 - 2028 (USD Million)
Table 73 Argentina Orthopedic Regenerative Surgical Products market, by application, 2016 - 2028 (USD Million)
Table 74 Argentina Products market, by allografts, 2016 - 2028 (USD Million)
Table 75 MEA Orthopedic Regenerative Surgical Products market, by country, 2016 - 2028 (USD Million)
Table 76 MEA Orthopedic Regenerative Surgical Products market, by product, 2016 - 2028 (USD Million)
Table 77 MEA Orthopedic Regenerative Surgical Products market, by end user, 2016 - 2028 (USD Million)
Table 78 MEA Orthopedic Regenerative Surgical Products market, by application, 2016 - 2028 (USD Million)
Table 79 MEA Products market, by allografts, 2016 - 2028 (USD Million)
Table 80 South Africa Orthopedic Regenerative Surgical Products market, by product, 2016 - 2028 (USD Million)
Table 81 South Africa Orthopedic Regenerative Surgical Products market, by end user, 2016 - 2028 (USD Million)
Table 82 South Africa Orthopedic Regenerative Surgical Products market, by application, 2016 - 2028 (USD Million)
Table 83 South Africa Products market, by allografts, 2016 - 2028 (USD Million)
Table 84 Saudi Arabia Orthopedic Regenerative Surgical Products market, by product, 2016 - 2028 (USD Million)
Table 85 Saudi Arabia Orthopedic Regenerative Surgical Products market, by end user, 2016 - 2028 (USD Million)
Table 86 Saudi Arabia Orthopedic Regenerative Surgical Products market, by application, 2016 - 2028 (USD Million)
Table 87 Saudi Arabia Products market, by allografts, 2016 - 2028 (USD Million)
Table 88 Global Orthopedic Regenerative Surgical Products market, by region, 2016 - 2028 (USD Million)
Table 89 Global Orthopedic Regenerative Surgical Products market, by product, 2016 - 2028 (USD Million)
Table 90 Global Orthopedic Regenerative Surgical Products market, by end user, 2016 - 2028 (USD Million)
Table 91 Global Orthopedic Regenerative Surgical Products market, by application, 2016 - 2028 (USD Million)
Table 92 Global Products market, by allografts, 2016 - 2028 (USD Million)
Table 93 Product Pipeline Analysis

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Commodity workflow analysis
Fig. 9 Orthopedic Regenerative Surgical Products market snapshot, 2020 (USD Million)
Fig. 10 Orthopedic Regenerative Surgical Products market segmentation and scope
Fig. 11 Parent market outlook
Fig. 12 Ancillary market outlook
Fig. 13 Penetration & growth prospect mapping, 2020
Fig. 14 Orthopedic Regenerative Surgical Products market dynamics analysis
Fig. 15 Orthopedic Regenerative Surgical Products market driver analysis
Fig. 16 Orthopedic Regenerative Surgical Products market restraint analysis
Fig. 17 COVID-19 disease prevalence
Fig. 18 Orthopedic Regenerative Surgical Products market: Product movement analysis, 2020 & 2028
Fig. 19 Orthopedic Regenerative Surgical Products market Product outlook: Key takeaways
Fig. 20 Allografts market, 2016 - 2028 (USD Million)
Fig. 21 Amniotic Products market, 2016 - 2028 (USD Million)
Fig. 22 Others market, 2016 - 2028 (USD Million)
Fig. 23 Synthetic market, 2016 - 2028 (USD Million)
Fig. 24 Cell-based market, 2016 - 2028 (USD Million)
Fig. 25 Viscosupplements market, 2016 - 2028 (USD Million)
Fig. 26 Orthopedic Regenerative Surgical Products market: End-user movement analysis 2020 & 2028
Fig. 27 Orthopedic Regenerative Surgical Products market End-user outlook: Key takeaways
Fig. 28 Hospitals market, 2016 - 2028 (USD Million)
Fig. 29 Ambulatory Surgical Centers market, 2016 - 2028 (USD Million)
Fig. 30 Others market, 2016 - 2028 (USD Million)
Fig. 31 Orthopedic Regenerative Surgical Products market: Application movement analysis, 2020 & 2028
Fig. 32 Orthopedic Regenerative Surgical Products market application outlook: Key takeaways
Fig. 33 Orthopedic Pain Management market, 2016 - 2028 (USD Million)
Fig. 34 Trauma Repair market, 2016 - 2028 (USD Million)
Fig. 35 Cartilage and Tendon Repair market, 2016 - 2028 (USD Million)
Fig. 36 Joint Reconstruction market, 2016 - 2028 (USD Million)
Fig. 37 Others market, 2016 - 2028 (USD Million)
Fig. 38 Orthopedic Regenerative Surgical Products market: Regional movement analysis 2020 & 2028
Fig. 39 Orthopedic Regenerative Surgical Products market regional outlook: Key takeaways
Fig. 40 North America Orthopedic Regenerative Surgical Products market share, by country, 2020
Fig. 41 North America Orthopedic Regenerative Surgical Products market, 2016 - 2028 (USD Million)
Fig. 42 U.S. Orthopedic Regenerative Surgical Products market, 2016 - 2028 (USD Million)
Fig. 43 Canada Orthopedic Regenerative Surgical Products market, 2016 - 2028 (USD Million)
Fig. 44 Europe Orthopedic Regenerative Surgical Products market share, by country, 2020
Fig. 45 Europe Orthopedic Regenerative Surgical Products market, 2016 - 2028 (USD Million)
Fig. 46 Germany Orthopedic Regenerative Surgical Products market, 2016 - 2028 (USD Million)
Fig. 47 France Orthopedic Regenerative Surgical Products market, 2016 - 2028 (USD Million)
Fig. 48 U.K. Orthopedic Regenerative Surgical Products market, 2016 - 2028 (USD Million)
Fig. 49 Italy Orthopedic Regenerative Surgical Products market, 2016 - 2028 (USD Million)
Fig. 50 Spain Orthopedic Regenerative Surgical Products market, 2016 - 2028 (USD Million)
Fig. 51 Asia Pacific Orthopedic Regenerative Surgical Products market share, by country, 2020
Fig. 52 Asia Pacific Orthopedic Regenerative Surgical Products market, 2016 - 2028 (USD Million)
Fig. 53 Japan Orthopedic Regenerative Surgical Products market, 2016 - 2028 (USD Million)
Fig. 54 China Orthopedic Regenerative Surgical Products market, 2016 - 2028 (USD Million)
Fig. 55 India Orthopedic Regenerative Surgical Products market, 2016 - 2028 (USD Million)
Fig. 56 Latin America Orthopedic Regenerative Surgical Products market share, by country, 2020
Fig. 57 Latin America Orthopedic Regenerative Surgical Products market, 2016 - 2028 (USD Million)
Fig. 58 Brazil Orthopedic Regenerative Surgical Products market, 2016 - 2028 (USD Million)
Fig. 59 Mexico Orthopedic Regenerative Surgical Products market, 2016 - 2028 (USD Million)
Fig. 60 Argentina Orthopedic Regenerative Surgical Products market, 2016 - 2028 (USD Million)
Fig. 61 MEA Orthopedic Regenerative Surgical Products market share, by country, 2020
Fig. 62 MEA Orthopedic Regenerative Surgical Products market, 2016 - 2028 (USD Million)
Fig. 63 South Africa Orthopedic Regenerative Surgical Products market, 2016 - 2028 (USD Million)
Fig. 64 Saudi Arabia Orthopedic Regenerative Surgical Products market, 2016 - 2028 (USD Million)
Fig. 65 Market participant categorization
Fig. 66 Company market position analysis
Fig. 67 Technology Trend analysis